In:
Circulation: Cardiovascular Quality and Outcomes, Ovid Technologies (Wolters Kluwer Health), Vol. 12, No. Suppl_1 ( 2019-04)
Abstract:
Objective: Characterize variations in healthcare resource use (HRU), costs, and ablation prevalence in younger women and men newly diagnosed with paroxysmal supraventricular tachycardia (PSVT). Methods: Commercially insured patients age 18-40 from the Truven Health MarketScan database with newly diagnosed PSVT (ICD-9: 427.0; ICD-10: I47.1) from October 2012 to September 2016, were included when observable one year before and after index diagnosis. The outcomes were mean annual per patient HRU and costs paid by insurers 1 year pre- and post-diagnosis. Results: Among 5,466 study patients, a majority were women (N=3,655; 66.9%). Newly diagnosed women were older (mean age: 30.4y vs. 29.4y; P 〈 0.0001), although there were no significant differences in the Charlson Comorbidity Index (CCI). Rates of hypertension (9.8% vs 15.3%), atrial fibrillation (0.8% vs 2.9%), and heart failure (1.3% vs 2.6%) were low, but significantly lower (p 〈 0.01) in women; chronic pulmonary disease (10.9% vs 8.3%) and anxiety (13.9% vs 10.9%) were significantly higher (p 〈 0.01) in women. Mean annual per patient costs increased for all patients in the post-index year relative to the pre-index year ($17,188 for women versus $25,279 for men, p 〈 0.05). Post-diagnosis costs were significantly lower for women ($26,922 vs $33,112, p 〈 0.05), reflecting lower spending for services with a PSVT diagnosis (women: $8,471 vs men: $11,405, p 〈 0.05). Fewer women were treated with cardiac ablation (12.6% vs. 15.3%; P 〈 0.01). Post-diagnosis rates of beta blocker and calcium channel blocker use were higher for women (46.1% vs. 44.2%; P 〈 0.05), with larger increases in the proportions of women newly prescribed these medications. Patients having at least 1 emergency department visit post-diagnosis (47.9%) and at least 1 hospital admission post-diagnosis (7.6%) were frequent, and these were both more prevalent in women (p 〈 0.01) [ Figure ]. Conclusion: Healthcare spending increases significantly in younger patients newly diagnosed with PSVT. Despite the fact that emergency department visits and hospital admissions are more common in women than men after a PSVT diagnosis, spending after a PSVT diagnosis is significantly lower for women, reflecting lower ablation rates and spending for services with a PSVT diagnosis.
Type of Medium:
Online Resource
ISSN:
1941-7713
,
1941-7705
DOI:
10.1161/hcq.12.suppl_1.274
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2019
detail.hit.zdb_id:
2453882-6
Bookmarklink